On July 21, 2020, the Commission premiered   a virtual meeting to help us better understand the potential for COVID-19’s reemergence, the country’s efforts to track the spread of the disease, and national readiness to address future biological threats.
More information about this meeting, including a full agenda, is available <a href='https://biodefensecommission.org/events/covid-complexities-converging-threats-fractured-resources/'>here.</a>

On July 21, 2020, the Commission premiered a virtual meeting to help us better understand the potential for COVID-19’s reemergence, the country’s efforts to track the spread of the disease, and national readiness to address future biological threats. More information about this meeting, including a full agenda, is available here.

On July 21, 2020, the Commission premiered   a&nbsp;virtual&nbsp;meeting to help us better understand the potential for COVID-19’s reemergence, the country’s efforts to track the spread of the disease, and national readiness to address future biological threats.
More information about this meeting, including a full agenda, is available <a href="https://biodefensecommission.org/events/covid-complexities-converging-threats-fractured-resources/" rel="noopener noreferrer">here.</a>

COVID Complexities: Converging Threats, Fractured Resources

The Bipartisan Commission on Biodefense is a privately funded entity established in 2014 to provide for a comprehensive assessment of the state of U.S. biodefense efforts and to issue recommendations that will foster change.

From 2014-2015, the Commission convened four public meetings in Washington, DC on biological threat awareness, prevention and protection, surveillance and detection, and response and recovery. Current and former Members of Congress, former Administration officials, state and local representatives, thought leaders, and other experts provided their perspectives on current biodefense efforts, including strengths, weaknesses, and opportunities. While much good work has been achieved toward biodefense, these meetings have revealed systemic challenges in the enterprise designed to protect Americans from biological events.

The Commission continues to advocate for uptake of these recommendations at the highest levels of American government, through additional meetings, reports, and other activities, and is the only such body of bipartisan, former high-level policymakers to do so.

Science

Education

Government

Life Sciences

The Bipartisan Commission on Biodefense is a privately funded entity established in 2014 to provide for a comprehensive assessment of the state of U.S. biodefense efforts and to issue recommendations that will foster change. From 2014-2015, the Commission convened four public meetings in Washington, DC on biological threat awareness, prevention and protection, surveillance and detection, and response and recovery. Current and former Members of Congress, former Administration officials, state and local representatives, thought leaders, and other experts provided their perspectives on current biodefense efforts, including strengths, weaknesses, and opportunities. While much good work has been achieved toward biodefense, these meetings have revealed systemic challenges in the enterprise designed to protect Americans from biological events. The Commission continues to advocate for uptake of these recommendations at the highest levels of American government, through additional meetings, reports, and other activities, and is the only such body of bipartisan, former high-level policymakers to do so.

Share COVID Complexities: Converging Threats, Fractured Resources

Sign up to save your podcasts

COVID Complexities: Converging Threats, Fractured Resources

COVID Complexities: Converging Threats, Fractured Resources